albert bourla pfizer - Search News

Our 2025 focus is on pipeline

Hosted on MSN · 2d

Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline

Albert Bourla, Pfizer chairman and CEO, joins CNBC's 'Power Lunch' to discuss the company's focus for 2025, whether bird flu is the next pandemic, and more.

Reuters on MSN · 3d

Pfizer going 'all in' on obesity drug development, CEO Bourla says

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday.

Business Insider · 2d

Pfizer CEO Bourla says Starboard Value wants minimal changes, Bloomberg says

CEO Albert Bourla said the company’s dispute with activist firm Starboard Value isn’t “an aggressive situation,” months after the

news.bloomberglaw · 2d

Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight

Pfizer Inc.’s dispute with activist firm Starboard Value LP isn’t “an aggressive situation,” Chief Executive Officer Albert Bourla said, months after the feared investor disclosed a stake in the company and questioned his management.

Defiant, Pfizer CEO talks about Trump, obesity drugs, and the ‘Pfizer machine’

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

2d

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

GlobalData on MSN2d

Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

Pfizer Cautiously Optimistic on Obesity Pill as Kailera Challenges Lilly’s Zepbound With Strong Phase II Data

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales

Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results